Please login to the form below

Not currently logged in
Email:
Password:

real world evidence

This page shows the latest real world evidence news and features for those working in and with pharma, biotech and healthcare.

AI company Sensyne raises £60m in IPO

AI company Sensyne raises £60m in IPO

guide the development of new drugs, as well as real-world evidence-based software to improve patient care and the conduct of clinical trials that could be of value to pharma ... The idea behind the software is that in addition to helping patients manage

Latest news

More from news
Approximately 11 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • The NHS in 2022: how pharma can contribute to new models of care The NHS in 2022: how pharma can contribute to new models of care

    That would probably include providing specialist expertise in a disease area, and articulating the true cost and impact of a disease and treatment through real world evidence (RWE). ... The industry should fully commit to joint working arrangements in

  • Leave or remain? Winning the employee referendum Leave or remain? Winning the employee referendum

    Overall turnover is misleading. The real measure of success is to track ‘regretted’turnover: high potential or high performers. ... aren’t swayed by promises on the sides of buses, but by the real-world evidence of their experiences in the workplace

  • Stakeholder dialogue in Europe’s adaptive pathways pilot Stakeholder dialogue in Europe’s adaptive pathways pilot

    Evidence suggests that medicines using the resulting accelerated access initiatives experience variable reimbursement outcomes due to uncertainties in the clinical or economic evidence base. ... The use of real-world evidence (RWE) as a complement to

  • The rise of vertical integration in the US payer landscape The rise of vertical integration in the US payer landscape

    PBM-medical management company merger: ESI/eviCore Healthcare. A traditional PBM, ESI announced it was purchasing eviCore Healthcare, a privately held company offering health plans and other risk-bearing, evidence-based ... Engaging in a decision support

  • 30 Women Leaders in UK Healthcare

    Dr Marshall is a world-leading expert in G-Protein-Coupled-Receptor (GPCR) biology and drug discovery. ... Bringing people together to make things happen across organisational lines, Angela is leading projects to exploit real-world evidence, adaptive

More from intelligence
Approximately 8 fully matching, plus 47 partially matching documents found.

Latest appointments

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “ Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

  • EMA's Dr Stella Blackburn joins Quintiles EMA's Dr Stella Blackburn joins Quintiles

    Quintiles has appointed Dr Stella Blackburn as vice president and global head of risk management for its real world and late phase research group. ... She said: “ Together with my colleagues at Quintiles, I aim to provide best-in-class solutions for

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • PRMA Consulting Ltd

    Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy.

  • How can pharma engage with key stakeholders on NHS service transformation?

    reconfiguration, states that clinical engagement and approval, and strong clinical evidence are key. ... By ensuring proposals are in line with the NHS England guidance and gathering as much clinical, and ideally real world, evidence as possible about

  • The Heart of the Matter 7: Reality Dawns

    But how can you turn Big Data into high-value Real-World Evidence (RWE)? ... That's when it truly becomes real-world evidence. Everything prior to that is just data.

  • The heart of the matter - Part Three

    The heart of the matter - Part Three. Is pharma doing enough to maximise real world evidence? ... In the modern game of pharma Buzzword Bingo, ‘ real world evidence’ (RWE) is likely to feature prominently on any winning card.

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics